Open AccessA PHASE I STUDY OF THE BTK INHIBITOR ABIVERTINIB (AC0010) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA
Author(s) -
Mingzhen Yang,
Jinwen Qian,
Jianmin Huang,
Yanmei Jiao,
Weiyan Tang,
Xin Xu,
Wei Xu,
Feng Luo,
Jie Jin
Publication year - 2019
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/02014419-201906001-00414
Subject(s) - bruton's tyrosine kinase , refractory (planetary science) , lymphoma , ibrutinib , medicine , cancer research , oncology , materials science , leukemia , chronic lymphocytic leukemia , receptor , tyrosine kinase , composite material